Table 2. The basic characteristics of the included studies (Part B).
| Author year | Diagnostic outcome | Procedure time | Complication rate | Cost | Ancillary test | Concordance between ROSE and final diagnosis | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adequacy | Diagnostic yield | Sensitivity for malignancy | R | NR | R | NR | ||||||
| Madan et al., 2016 | ||||||||||||
| c-TBNA | NA | Reported | NA | 21±2.8 | 20±3.8 | 0/20 | 1/20 | NA | NA | NA | ||
| EBUS-TBNA | NA | Reported | NA | 25±4.8 | 25±4.9 | 2/20 | 1/20 | NA | NA | NA | ||
| Yarmus et al., 2011 | Reported | Reported | Reported | 29.5 | 27.6 | NA | NA | NA | NA | NA | ||
| Oki et al.2013 | NA | Reported | Reported | 22.3±15.9 | 22.1±7.7 | 0/55 | 0/53 | NA | NA | NA | ||
| Trisolini et al., 2015 | Reporteda | Reported | NA | 17.8±8.34 | 17.9±5.61 | 3/98 | 4/99 | NA | Reported | NA | ||
| Trisolini et al., 2011 | Reporteda | Reported | NA | NA | NA | 5/83 | 17/85 | NA | NA | Reported | ||
| Murakami et al., 2013 | NA | Reported | Reported | NA | NA | 0/77 | 0/23 | NA | NA | NA | ||
| Li et al., 2014 | NA | Reported | Reported | NA | NA | 4/37 | 10/32 | Reported | NA | Reported | ||
| Chin et al., 2002 | NA | Reported | NA | NA | NA | NA | NA | NA | NA | NA | ||
| Bruno et al., 2013 | NA | Reported | Reported | NA | NA | NA | NA | Reported | NA | NA | ||
| Gianella et al., 2018 | NA | NA | Reported | NA | NA | NA | NA | NA | NA | NA | ||
| Cardoso et al., 2015 | Reported | Reported | Reported | NA | NA | 0/41 | 0/40 | NA | NA | NA | ||
| Mondoni et al., 2013 | NA | Reported | Reported | NA | NA | NA | NA | NA | NA | NA | ||
| Baram et al., 2005 | NA | Reporteda | Reporteda | 39±20 | 39±14 | 0/32 | 0/12 | NA | NA | Reported | ||
| Chen et al., 2015 | NA | Reported | NA | 28.12±6.67 | 27.7±8.40 | NA | NA | NA | NA | Reported | ||
| Diette et al., 2000 | NA | Reported | NA | 39.1 | 32.6 | NA | NA | NA | NA | Report | ||
| Austin et al., 1993 | NA | Reported | Reported | NA | NA | 4/25 | 2/30 | NA | NA | NA | ||
| Santambrogio et al., 1997 | Reported | NA | Reported | NA | NA | 29/110 | 23/110 | NA | NA | NA | ||
| Saleh et al., 1996 | NA | Reported | NA | NA | NA | NA | NA | NA | NA | NA | ||
| Küçük et al., 2004 | Reported | Reported | Reported | NA | NA | 7/48 | 6/48 | NA | NA | NA | ||
| Davenport et al., 1990 | Reporteda | NA | Reporteda | NA | NA | NA | NA | NA | NA | Reported | ||
| Collins et al., 2012 | Reporteda | Reporteda | NA | NA | NA | NA | NA | NA | NA | NA | ||
| Gariffin et al., 2010 | ||||||||||||
| Lymph nodes | NA | Repprteda | NA | NA | NA | NA | NA | NA | Reported | NA | ||
| Lung lesions | NA | Repprteda | NA | NA | NA | NA | NA | NA | NA | |||
| Guo et al., 2015 | Reported | Repprteda | NA | 37.6 | 37.4 | 0/122 | 0/114 | NA | NA | NA | ||
| Xiang et al., 2018 | Reported | Reported | Reported | NA | NA | 1/81 | 7/60 | NA | NA | Reported | ||
| Chaiyakul et al., 2018 | NA | Reported | NA | 32.33±6.50 | 50.32±4.99 | NA | NA | NA | NA | Reported | ||
| Wong et al., 2014 | NA | NA | NA | NA | NA | NA | NA | NA | Reported | Reported | ||
| Kern et al., 2012 | NA | Reported | NA | NA | NA | NA | NA | NA | NA | NA | ||
a, reported in per-lesion or per-speciman basis. c-TBNA, conventional transbronchial needle aspiration; EBUS, endobronchial ultrasound; ROSE, rapid on-site evaluation; NR, without rapid on-site evaluation; NA, not available.